AI Summary
Aehr reported a strong Q4 with $18.8M revenue, record $60.7M bookings, and $80.6M backlog. For FY2026, revenue was $50.0M and non-GAAP profit turned positive, while GAAP loss narrowed. The company guides FY2027 revenue of $130–$150M (up roughly 160–200% YoY) supported by an ~$100M backlog, broad AI, silicon photonics, and SiC/GaN opportunities.
Sentiment Rationale
Record quarterly bookings and a clear, multi-year revenue pathway (~160–200% YoY) with a substantial backlog reduce execution risk and may prompt multiple expansion as orders convert to revenue; positive non-GAAP profitability in Q4 reinforces margin trajectory; large cash balance supports capacity to invest and weather near-term volatility. Similar precedents include peers that gain from backlog-driven upgrades and AI/data-center demand cycles.
Trading Thesis
Bullish over 12–18 months as backlog drives sustained revenue growth and margin expansion.
Market-Moving
- Fiscal 2027 revenue guidance of $130–$150M signals substantial growth trajectory.
- Backlog of about $100M provides near-term revenue visibility into 2027.
- Benchmarking with a leading AI processor supplier implies potential multi-device pilots.
- Rising SiC/GaN auto and silicon photonics demand supports WLBI and package burn-in.
Key Facts
- Q4 2026 revenue $18.8M; bookings $60.7M; backlog $80.6M.
- Fiscal 2026 revenue $50.0M; net loss GAAP $(7.1)M; non-GAAP $0.9M.
- FY2027 guided revenue $130–$150M; backlog ~ $100M; non-GAAP margin 18–22%.
- AI WLBI, silicon photonics, and SiC/GaN demand driving multi-year growth.
Companies Mentioned
- Aehr Test Systems (AEHR): Primary company; record bookings and strong backlog drive revenue visibility and guidance.
- Major AI processor supplier (N/A): Benchmark testing exceeded expectations; potential pilot production test validation may yield near-term revenue.
- Automotive SiC/GaN suppliers (N/A): Engagements and $8M in new SiC WLBI WaferPak orders; automotive electrification growth potential.
Earnings
Category: Earnings. The release centers on quarterly and annual results, backlog, and forward revenue guidance, fitting an earnings-oriented assessment of AEHR’s growth trajectory and monetization potential.